Vetbiolix
PrivateLast Round
Series A
Dec 2, 2024
Total Funding Raised
$6.7M
Company Overview
Vetbiolix operates in Healthcare & Life Sciences and is based in Loos. Its latest recorded funding round was a Series A round in December 2024.
Vetbiolix is a biotechnology company that develops innovative prescription medicines and care products for the treatment and prevention of diseases affecting pets, focusing on periodontitis, osteoarthritis, and gut motility disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetbiolix Comparables
Compare Vetbiolix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Okava Pharmaceuticals | 84% | |
| Vetigenics Inc. | 79% | |
| Vetbiobank | 78% |
For institutional investors. Book with your work email.
Vetbiolix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 2, 2024 | ||||
| Seed | Sep 12, 2022 |
For institutional investors. Book with your work email.
Vetbiolix Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors increased 219% MoM, reaching 1.7K.
- May 16, 2026
Monthly visitors grew 124% MoM, from 241 to 541.
For institutional investors. Book with your work email.
Vetbiolix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vetbiolix's valuation, stock price, and market status.
Is Vetbiolix a public or private company?
Vetbiolix is a private company.
What is the current stock price of Vetbiolix?
Vetbiolix is a private company, so its shares have no public market price. Caplight tracks Vetbiolix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vetbiolix worth (valuation)?
Valuation information for Vetbiolix is not publicly available.
Can I buy Vetbiolix stock?
Vetbiolix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vetbiolix's last funding round?
Vetbiolix's most recent funding round was Series A on December 2, 2024.
Who are the main investors in Vetbiolix?
Key investors in Vetbiolix include Tudigo, Eurasanté, Bpifrance.
Will Vetbiolix IPO soon?
No public IPO plans have been announced for Vetbiolix.
How can I track Vetbiolix secondary market activity?
Caplight tracks bids, offers, and trades in Vetbiolix's shares on secondary markets.